Literature DB >> 26554827

p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.

Claudia Meier1, Philip Hardtstock1, Sophie Joost1, Vijay Alla1, Brigitte M Pützer2.   

Abstract

Cancer stem-like cells (CSC) have been proposed to promote cancer progression by initiating tumor growth at distant sites, suggesting that stem-like cell features can support metastatic efficiency. Here, we demonstrate that oncogenic DNp73, a dominant-negative variant of the tumor-suppressor p73, confers cancer cells with enhanced stem-like properties. DNp73 overexpression in noninvasive melanoma and lung cancer cells increased anchorage-independent growth and elevated the expression of the pluripotency factors CD133, Nanog, and Oct4. Conversely, DNp73 depletion in metastatic cells downregulated stemness genes, attenuated sphere formation and reduced the tumor-initiating capability of spheroids in tumor xenograft models. Mechanistic investigations indicated that DNp73 acted by attenuating expression of miR-885-5p, a direct regulator of the IGF1 receptor (IGF1R) responsible for stemness marker expression. Modulating this pathway was sufficient to enhance chemosensitivity, overcoming DNp73-mediated drug resistance. Clinically, we established a correlation between low p73 function and high IGF1R/CD133/Nanog/Oct4 levels in melanoma specimens that associated with reduced patient survival. Our work shows how DNp73 promotes cancer stem-like features and provides a mechanistic rationale to target the DNp73-IGF1R cascade as a therapeutic strategy to eradicate CSC. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26554827     DOI: 10.1158/0008-5472.CAN-15-1228

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  p53 family members regulate cancer stem cells.

Authors:  Subhasree Basu; Maureen E Murphy
Journal:  Cell Cycle       Date:  2016-04-08       Impact factor: 4.534

2.  Expression profiling of microRNAs in human bone tissue from postmenopausal women.

Authors:  Laura De-Ugarte; Jenny Serra-Vinardell; Lara Nonell; Susana Balcells; Magdalena Arnal; Xavier Nogues; Leonardo Mellibovsky; Daniel Grinberg; Adolfo Diez-Perez; Natalia Garcia-Giralt
Journal:  Hum Cell       Date:  2017-09-20       Impact factor: 4.174

Review 3.  p73 isoforms meet evolution of metastasis.

Authors:  Stella Logotheti; Athanasia Pavlopoulou; Stephan Marquardt; Işıl Takan; Alexandros G Georgakilas; Thorsten Stiewe
Journal:  Cancer Metastasis Rev       Date:  2022-08-11       Impact factor: 9.237

Review 4.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

5.  Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation.

Authors:  Magdalena Olbryt; Aleksandra Rusin; Izabela Fokt; Anna Habryka; Patrycja Tudrej; Sebastian Student; Aleksander Sochanik; Rafał Zieliński; Waldemar Priebe
Journal:  Invest New Drugs       Date:  2017-04-17       Impact factor: 3.850

6.  A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.

Authors:  Thibault Voeltzel; Mario Flores-Violante; Florence Zylbersztejn; Sylvain Lefort; Marion Billandon; Sandrine Jeanpierre; Stéphane Joly; Gaelle Fossard; Milen Milenkov; Frédéric Mazurier; Ali Nehme; Amine Belhabri; Etienne Paubelle; Xavier Thomas; Mauricette Michallet; Fawzia Louache; Franck-Emmanuel Nicolini; Claude Caron de Fromentel; Véronique Maguer-Satta
Journal:  Cell Death Dis       Date:  2018-09-27       Impact factor: 8.469

7.  p73 regulates epidermal wound healing and induced keratinocyte programming.

Authors:  J Scott Beeler; Clayton B Marshall; Paula I Gonzalez-Ericsson; Timothy M Shaver; Gabriela L Santos Guasch; Spencer T Lea; Kimberly N Johnson; Hailing Jin; Bryan J Venters; Melinda E Sanders; Jennifer A Pietenpol
Journal:  PLoS One       Date:  2019-06-19       Impact factor: 3.240

Review 8.  Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.

Authors:  Hui Hua; Qingbin Kong; Jie Yin; Jin Zhang; Yangfu Jiang
Journal:  J Hematol Oncol       Date:  2020-06-03       Impact factor: 17.388

9.  Sedentary and Trained Older Men Have Distinct Circulating Exosomal microRNA Profiles at Baseline and in Response to Acute Exercise.

Authors:  Venugopalan D Nair; Yongchao Ge; Side Li; Hanna Pincas; Nimisha Jain; Nitish Seenarine; Mary Anne S Amper; Bret H Goodpaster; Martin J Walsh; Paul M Coen; Stuart C Sealfon
Journal:  Front Physiol       Date:  2020-06-10       Impact factor: 4.566

10.  LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.

Authors:  Stella Logotheti; Stephan Marquardt; Shailendra K Gupta; Christin Richter; Berdien A H Edelhäuser; David Engelmann; Julia Brenmoehl; Christoph Söhnchen; Nico Murr; Michael Alpers; Krishna P Singh; Olaf Wolkenhauer; Dirk Heckl; Alf Spitschak; Brigitte M Pützer
Journal:  Theranostics       Date:  2020-07-29       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.